chr1-1512426-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_001170535.3(ATAD3A):c.158C>T(p.Thr53Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00000371 in 1,079,372 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 29)
Exomes 𝑓: 0.0000037 ( 0 hom. )
Consequence
ATAD3A
NM_001170535.3 missense
NM_001170535.3 missense
Scores
3
13
3
Clinical Significance
Conservation
PhyloP100: 5.23
Genes affected
ATAD3A (HGNC:25567): (ATPase family AAA domain containing 3A) This gene encodes a ubiquitously expressed mitochondrial membrane protein that contributes to mitochondrial dynamics, nucleoid organization, protein translation, cell growth, and cholesterol metabolism. This gene is a member of the ATPase family AAA-domain containing 3 gene family which, in humans, includes two other paralogs. Naturally occurring mutations in this gene are associated with distinct neurological syndromes including Harel-Yoon syndrome. High-level expression of this gene is associated with poor survival in breast cancer patients. A homozygous knockout of the orthologous gene in mice results in embryonic lethality at day 7.5 due to growth retardation and defective development of the trophoblast lineage. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 1-1512426-C-T is Pathogenic according to our data. Variant chr1-1512426-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 225697.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATAD3A | NM_001170535.3 | c.158C>T | p.Thr53Ile | missense_variant | 1/16 | ENST00000378756.8 | NP_001164006.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATAD3A | ENST00000378756.8 | c.158C>T | p.Thr53Ile | missense_variant | 1/16 | 1 | NM_001170535.3 | ENSP00000368031 | P1 | |
ATAD3A | ENST00000378755.9 | c.158C>T | p.Thr53Ile | missense_variant | 1/16 | 2 | ENSP00000368030 | |||
ATAD3A | ENST00000672388.1 | n.262C>T | non_coding_transcript_exon_variant | 1/14 | ||||||
ATAD3A | ENST00000339113.9 | c.44C>T | p.Thr15Ile | missense_variant, NMD_transcript_variant | 1/17 | 2 | ENSP00000339421 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD3 genomes
Cov.:
29
GnomAD4 exome AF: 0.00000371 AC: 4AN: 1079372Hom.: 0 Cov.: 31 AF XY: 0.00000391 AC XY: 2AN XY: 511802
GnomAD4 exome
AF:
AC:
4
AN:
1079372
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
511802
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 29
GnomAD4 genome
Cov.:
29
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Harel-Yoon syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 29, 2016 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2017 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine | Apr 26, 2016 | homozygous variant identified in siblings - |
Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Apr 04, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Benign
T;D
Polyphen
1.0
.;D
Vest4
MutPred
Loss of phosphorylation at T53 (P = 0.0203);Loss of phosphorylation at T53 (P = 0.0203);
MVP
MPC
1.1
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at